LENZ Therapeutics Inc
LENZ29.330USD
-0.630-2.10%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
29.330USD+29.330After-hours (ET)
835.91MMarket Cap
LossP/E TTM
LENZ Therapeutics Inc
29.330
-0.630-2.10%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
5.24%16.93M
4.27%15.22M
-5.36%12.95M
-31.54%14.35M
-32.59%16.09M
-45.42%14.60M
-47.70%13.68M
-21.71%20.96M
-8.06%23.87M
41.24%26.75M
79.11%26.15M
52.72%26.78M
177.09%25.96M
--18.94M
287.94%14.60M
1257.04%17.53M
7642.15%9.37M
--3.76M
--1.29M
--121.00K
R&D expenses
-44.79%5.82M
--5.87M
170.60%6.45M
-48.59%6.95M
-35.13%10.54M
-100.00%0.00
-86.97%2.38M
-24.01%13.51M
-10.97%16.24M
64.77%18.46M
110.78%18.30M
40.34%17.78M
239.33%18.25M
--11.21M
275.89%8.68M
2894.56%12.67M
--5.38M
--2.31M
--423.00K
--0.00
Depreciation, depletion, and amortization
620.00%36.00K
-82.39%25.00K
-98.75%10.00K
-97.88%18.00K
-99.29%5.00K
-79.71%142.00K
14.29%800.00K
41.50%849.00K
59.09%700.00K
112.12%700.00K
250.00%700.00K
417.24%600.00K
340.00%440.00K
--330.00K
354.55%200.00K
11500.00%116.00K
--100.00K
--44.00K
--1.00K
--0.00
Other operating expenses
----
----
----
----
----
--1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-5.24%-16.93M
-4.27%-15.22M
5.36%-12.95M
31.54%-14.35M
32.59%-16.09M
45.42%-14.60M
47.70%-13.68M
21.71%-20.96M
8.06%-23.87M
-41.24%-26.75M
-79.11%-26.15M
-52.72%-26.78M
-177.09%-25.96M
---18.94M
-287.94%-14.60M
-1257.04%-17.53M
-7642.15%-9.37M
---3.76M
---1.29M
---121.00K
Net non-operating interest income (expenses)
Non-operating interest income
194.80%2.32M
--2.57M
--2.74M
--2.46M
--788.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--20.00K
--20.00K
Special income (expenses)
----
----
----
----
----
---10.95M
---11.35M
---36.90M
---2.58M
----
----
----
----
----
----
----
----
----
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
--0.00
--0.00
---300.00K
---71.00K
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
99.18%-11.00K
-89.33%8.00K
98.55%-6.00K
--1.64M
---1.35M
-96.51%75.00K
-128.06%-413.00K
----
----
21420.00%2.15M
14620.00%1.47M
20900.00%840.00K
101.19%123.00K
--10.00K
-97.37%10.00K
--4.00K
---10.34M
--380.00K
--0.00
--0.00
Income before tax
12.19%-14.62M
44.80%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
-1236.05%-17.53M
-13878.01%-19.71M
---3.38M
---1.31M
---141.00K
Income tax
----
--1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
12.19%-14.62M
44.80%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
-1236.05%-17.53M
-13878.01%-19.71M
---3.38M
---1.31M
---141.00K
Net income from continuous operations
12.19%-14.62M
44.79%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
-1236.05%-17.53M
-13878.01%-19.71M
---3.38M
---1.31M
---141.00K
Other net gains and losses
----
---1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
12.19%-14.62M
44.79%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
-1236.05%-17.53M
-13878.01%-19.71M
---3.38M
---1.31M
---141.00K
Net income attributable to common shareholders
12.19%-14.62M
44.79%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
-1236.05%-17.53M
-13878.01%-19.71M
---3.38M
---1.31M
---141.00K
Basic earnings per share
84.95%-0.53
83.44%-0.46
86.32%-0.38
94.13%-0.40
-17.67%-3.53
10.21%-2.77
12.17%-2.75
-105.11%-6.82
10.44%-3.00
-25.17%-3.09
-61.68%-3.13
-51.77%-3.33
-40.97%-3.35
---2.47
-374.55%-1.94
-1286.19%-2.19
-13865.02%-2.38
---0.41
---0.16
---0.02
Diluted earnings per share
84.95%-0.53
83.44%-0.46
86.32%-0.38
94.13%-0.40
-17.67%-3.53
10.21%-2.77
12.17%-2.75
-105.11%-6.82
10.44%-3.00
-25.17%-3.09
-61.68%-3.13
-51.77%-3.33
-40.97%-3.35
---2.47
-374.55%-1.94
-1286.19%-2.19
-13865.02%-2.38
---0.41
---0.16
---0.02
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
